Saturday 17 October 2026
Export DLB’s income statement to Excel — free account
Dolby Laboratories
DLB Industrials Specialty Business Services
Dolby Laboratories' revenue for fiscal 2025 (year ended September 2025) was $1.3 billion, up 5.92% from fiscal 2024. In the quarter to June 2026, revenue fell 3.34%, EPS fell 37.5% and free cash flow grew 157.4%, each against the same quarter a year earlier. Dividend growth for ten consecutive years.
59.95
0.88
−1.45%
Follow DLB
| Sep '16 | Sep '17 | Sep '18 | Sep '19 | Sep '20 | Sep '21 | Sep '22 | Sep '23 | Sep '24 | Sep '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | 6 | 5 | 7 | 7 | 7 | 6 | 7 | 7 | 6 |
P/E ratio |
29.35 | 29.08 | 150.83 | 25.75 | 28.69 | 28.66 | 35.41 | 38.43 | 28.03 | 27.21 |
Altman Z-Score |
12.13 | 11.28 | 10.99 | 10.10 | 10.70 | 13.17 | 11.29 | 9.72 | 9.15 | 9.17 |
P/S ratio |
5.33 | 5.45 | 6.79 | 5.29 | 5.74 | 6.95 | 5.20 | 5.95 | 5.74 | 5.14 |
P/FCF ratio |
39.54 | 21.58 | 26.84 | 30.68 | 24.25 | 21.88 | 25.14 | 23.77 | 25.59 | 16.13 |
Altman Z″-Score (non-manufacturers) |
11.23 | 11.09 | 10.87 | 10.57 | 11.46 | 11.99 | 11.21 | 9.55 | 9.00 | 9.78 |
Beneish M-Score |
(2.97) | (2.87) | (1.92) | (2.45) | (2.73) | (2.50) | (2.60) | (2.75) | (2.21) | (2.80) |
P/Operating CF |
71.84 | 73.22 | 64.11 | 50.35 | 59.16 | 81.12 | 126.96 | 90.91 | 62.94 | 56.48 |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 85 |
P/B ratio |
2.76 | 2.75 | 3.02 | 2.84 | 2.73 | 3.42 | 2.89 | 3.26 | 2.94 | 2.64 |
Price to Tangible BV |
3.76 | 3.58 | 3.85 | 3.66 | 3.42 | 4.16 | 3.67 | 4.30 | 4.81 | 4.07 |
EV/Sales |
4.71 | 4.64 | 5.75 | 4.55 | 4.77 | 5.96 | 4.54 | 5.21 | 5.29 | 4.55 |
EV/EBITDA |
15.05 | 14.98 | 22.67 | 16.48 | 16.71 | 16.65 | 18.28 | 21.82 | 19.65 | 16.90 |
EV/Operating CF |
13.40 | 13.25 | 17.20 | 17.23 | 16.11 | 17.05 | 17.88 | 18.45 | 20.58 | 13.01 |
EV/FCF |
34.90 | 18.35 | 22.71 | 26.36 | 20.15 | 18.75 | 21.99 | 20.82 | 23.57 | 14.28 |
Quick Ratio |
3.37 | 3.89 | 4.45 | 3.63 | 4.89 | 4.77 | 3.82 | 2.89 | 2.14 | 2.57 |
Current Ratio |
3.57 | 4.12 | 5.25 | 4.50 | 5.79 | 5.58 | 4.72 | 3.52 | 2.86 | 3.17 |
Net Debt/EBITDA |
(2.00) | (2.64) | (4.13) | (2.70) | (3.40) | (2.77) | (2.62) | (3.08) | (1.69) | (2.18) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.46 | 0.45 | 0.39 | 0.44 | 0.40 | 0.43 | 0.43 | 0.46 | 0.42 | 0.43 |
Operating CF/Net income |
1.94 | 1.83 | 8.44 | 1.28 | 1.49 | 1.44 | 1.73 | 1.83 | 1.25 | 1.85 |
Capex/Depreciation |
(2.49) | (1.20) | (1.02) | (1.33) | (0.61) | (0.33) | (0.57) | (0.32) | (0.36) | (0.43) |
Interest Coverage |
1,854.36 | 1,945.93 | 926.79 | 1,512.22 | 1,176.03 | 114.80 | 29.52 | 7.71 | — | — |
| 9.80% | 10.02% | 1.85% | 10.90% | 9.74% | 12.30% | 7.58% | 8.68% | 10.78% | 9.96% | |
| 8.37% | 8.53% | 1.55% | 8.97% | 8.06% | 10.30% | 6.35% | 7.08% | 8.60% | 8.05% | |
ROIC |
10.83% | 12.24% | 9.05% | 11.57% | 10.42% | 16.16% | 9.01% | 9.53% | 8.46% | 9.01% |
Return on Tangible Assets |
18.77% | 16.51% | 2.42% | 15.83% | 12.70% | 15.67% | 11.90% | 12.97% | 20.85% | 17.95% |
Average Days of Receivables |
26.93 | 24.92 | 57.50 | 55.59 | 56.66 | 66.26 | 70.91 | 73.64 | 90.40 | 89.58 |
Research and Development Expense of Revenue |
21.41% | 21.60% | 22.45% | 19.16% | 20.58% | 19.80% | 20.83% | 20.89% | 20.70% | 19.40% |
Selling, General and Administrative Expense of Revenue |
45.25% | 43.36% | 48.09% | 44.24% | 47.83% | 43.46% | 50.57% | 47.15% | 47.49% | 47.97% |
Intangible Assets out of Total Assets |
0.23 | 0.20 | 0.18 | 0.18 | 0.17 | 0.15 | 0.18 | 0.19 | 0.31 | 0.29 |
Share Based Compensation of Revenue |
6.53% | 6.05% | 6.76% | 6.17% | 7.46% | 7.78% | 9.17% | 9.12% | 9.41% | 9.53% |
Graham Net Nets |
0.08 | 0.11 | 0.14 | 0.13 | 0.16 | 0.14 | 0.13 | 0.11 | 0.08 | 0.11 |
Graham Number |
28.60 | 30.71 | 15.40 | 35.85 | 35.50 | 42.16 | 30.53 | 34.21 | 39.99 | 40.54 |
Earnings Yield |
3.41% | 3.44% | 0.66% | 3.88% | 3.49% | 3.49% | 2.82% | 2.60% | 3.57% | 3.68% |
Free Cash Flow Yield |
2.53% | 4.63% | 3.73% | 3.26% | 4.12% | 4.57% | 3.98% | 4.21% | 3.91% | 6.20% |
Revenue per Share |
10.18 | 10.61 | 10.20 | 12.22 | 11.55 | 12.66 | 12.54 | 13.57 | 13.33 | 14.07 |
Operating CF per Share |
3.58 | 3.71 | 3.41 | 3.22 | 3.42 | 4.42 | 3.19 | 3.83 | 3.43 | 4.93 |
Capex per Share |
(2.20) | (1.03) | (0.83) | (1.12) | (0.69) | (0.38) | (0.59) | (0.32) | (0.31) | (0.44) |
Free Cash Flow per Share |
1.37 | 2.68 | 2.58 | 2.11 | 2.73 | 4.05 | 2.59 | 3.52 | 3.11 | 4.49 |
Cash per Share |
6.37 | 8.67 | 10.67 | 9.10 | 11.21 | 12.57 | 8.18 | 9.99 | 6.05 | 8.28 |
Shareholders Equity per Share |
19.65 | 21.06 | 22.93 | 22.76 | 24.25 | 25.74 | 22.51 | 24.77 | 26.03 | 27.45 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
19.65 | 21.06 | 22.93 | 22.76 | 24.25 | 25.74 | 22.51 | 24.77 | 26.03 | 27.45 |
Free Cash Flow |
138.28 | 272.93 | 266.85 | 214.14 | 274.86 | 409.66 | 259.12 | 336.74 | 297.25 | 430.26 |
Working Capital |
546.65 | 765.66 | 1,211.38 | 1,074.69 | 1,280.09 | 1,444.78 | 1,033.38 | 1,065.58 | 776.58 | 950.47 |
Capital Expenditures |
(221.78) | (104.87) | (85.36) | (113.54) | (68.99) | (38.09) | (59.46) | (30.34) | (30.01) | (41.94) |
Net Current Asset Value |
428.36 | 621.72 | 1,001.69 | 872.82 | 1,068.28 | 1,259.04 | 872.37 | 880.22 | 571.38 | 792.45 |
EV/EBIT |
20.82 | 20.26 | 33.02 | 21.96 | 25.32 | 22.16 | 27.57 | 31.39 | 26.07 | 23.19 |
Capex to Sales |
0.22 | 0.10 | 0.08 | 0.09 | 0.06 | 0.03 | 0.05 | 0.02 | 0.02 | 0.03 |
Price to Operating Income |
23.59 | 23.83 | 39.03 | 25.55 | 30.47 | 25.86 | 31.53 | 35.82 | 28.31 | 26.19 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.20 | 0.18 | 0.16 | 0.16 | 0.21 | 0.21 | 0.20 | 0.20 | 0.18 | 0.21 |
Cash ROIC |
5.28% | 9.02% | 7.68% | 6.61% | 7.71% | 10.57% | 8.44% | 10.11% | 9.70% | 12.56% |
Accounts Receivable Turnover |
11.57 | 14.46 | 8.79 | 6.99 | 6.29 | 6.21 | 5.27 | 5.14 | 4.41 | 4.17 |
Accounts Payable Turnover |
5.70 | 7.43 | 7.03 | 8.66 | 10.53 | 8.56 | 8.85 | 8.69 | 7.34 | 9.09 |
Inventory Turnover |
7.21 | 5.73 | 4.98 | 5.50 | 5.06 | 7.12 | 8.19 | 5.16 | 4.05 | 4.99 |
Average Days of Payables |
58.76 | 44.26 | 62.73 | 34.52 | 31.44 | 49.91 | 36.59 | 50.06 | 45.15 | 40.66 |
Days of Inventory on Hand |
54.77 | 77.14 | 74.98 | 73.36 | 63.66 | 30.78 | 60.80 | 85.22 | 87.62 | 69.35 |
Average Receivables |
88.63 | 74.72 | 119.94 | 177.62 | 184.73 | 206.47 | 238.10 | 252.92 | 288.86 | 323.28 |
Average Payables |
19.13 | 15.96 | 18.15 | 18.57 | 13.91 | 15.20 | 15.98 | 17.55 | 19.15 | 17.61 |
Average Inventory |
15.11 | 20.70 | 25.63 | 29.27 | 28.94 | 18.26 | 17.26 | 29.59 | 34.68 | 32.08 |
Average Assets |
2,221.70 | 2,421.83 | 2,699.47 | 2,843.57 | 2,869.54 | 3,011.51 | 2,897.62 | 2,834.66 | 3,044.85 | 3,168.84 |
Average Common Equity |
1,897.37 | 2,061.29 | 2,257.17 | 2,341.77 | 2,375.72 | 2,521.32 | 2,427.63 | 2,311.60 | 2,429.54 | 2,559.42 |
Columns are period end dates